Dr. Bush has focused on airway and pulmonary vascular complications in children with Down syndrome. His research aims to improve our understanding of the genetic contributions from the 21st chromosome towards the development of lung hypoplasia and pulmonary hypertension in the Down syndrome population. More specifically, he is interested in the effects of over-expressed chromosome 21 encoded anti-angiogenic factors on lung and vascular development in children with Down syndrome. In addition to his work with the Down syndrome population, his ongoing work (in conjunction with Dr. Alfin Vicencio) focuses on the airway microbiome and fungal disease in severe, refractory asthmatics.
MD, St. George's University School of Medicine
Residency, Pediatrics, Steven & Alexandra Cohen Children's Medical Center
Fellowship, Pediatric Pulmonology, Children's Hospital Colorado